-
Activated human NK cells can stimulate resting B cells to secrete immunoglobulin.
J Immunol. 1995 Jun 1;154(11):5656-64
PMID: 7751617
-
Use of CpG oligodeoxynucleotides as immune adjuvants.
Immunol Rev. 2004 Jun;199:201-16
PMID: 15233736
-
Clonal selection and learning in the antibody system.
Nature. 1996 Jun 27;381(6585):751-8
PMID: 8657279
-
MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice.
Vaccine. 1996 Apr;14(6):478-84
PMID: 8782343
-
Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells.
Science. 1997 Feb 14;275(5302):977-9
PMID: 9020080
-
Mouse CD1-specific NK1 T cells: development, specificity, and function.
Annu Rev Immunol. 1997;15:535-62
PMID: 9143699
-
Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells.
J Exp Med. 1997 Jul 7;186(1):109-20
PMID: 9207002
-
Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors.
Science. 1997 Nov 28;278(5343):1623-6
PMID: 9374462
-
CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.
Science. 1997 Nov 28;278(5343):1626-9
PMID: 9374463
-
CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution.
J Exp Med. 1998 Oct 19;188(8):1521-8
PMID: 9782129
-
The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids.
Annu Rev Immunol. 1999;17:297-329
PMID: 10358761
-
Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype.
J Immunol. 1999 Sep 1;163(5):2373-7
PMID: 10452969
-
Lysosomal glycosphingolipid recognition by NKT cells.
Science. 2004 Dec 3;306(5702):1786-9
PMID: 15539565
-
alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles.
Nat Rev Immunol. 2005 Jan;5(1):31-42
PMID: 15630427
-
Aluminium compounds for use in vaccines.
Immunol Cell Biol. 2004 Oct;82(5):497-505
PMID: 15479435
-
Mice lacking MHC class II molecules.
Cell. 1991 Sep 6;66(5):1051-66
PMID: 1909605
-
Generation and analysis of interleukin-4 deficient mice.
Science. 1991 Nov 1;254(5032):707-10
PMID: 1948049
-
Freund's complete adjuvant: an effective but disagreeable formula.
Res Immunol. 1992 Jun;143(5):478-83; discussion 572
PMID: 1439126
-
Activation of B lymphocytes by NK cells.
Int Immunol. 1992 Dec;4(12):1373-80
PMID: 1286061
-
Immune response in mice that lack the interferon-gamma receptor.
Science. 1993 Mar 19;259(5102):1742-5
PMID: 8456301
-
An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans.
J Exp Med. 1994 Sep 1;180(3):1097-106
PMID: 7520467
-
An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells.
J Exp Med. 1994 Sep 1;180(3):1171-6
PMID: 8064234
-
Maintenance of serum antibody levels.
Annu Rev Immunol. 2005;23:367-86
PMID: 15771575
-
Recognition of bacterial glycosphingolipids by natural killer T cells.
Nature. 2005 Mar 24;434(7032):520-5
PMID: 15791257
-
Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections.
Nature. 2005 Mar 24;434(7032):525-9
PMID: 15791258
-
NKT cell stimulation with glycolipid antigen in vivo: costimulation-dependent expansion, Bim-dependent contraction, and hyporesponsiveness to further antigenic challenge.
J Immunol. 2005 Sep 1;175(5):3092-101
PMID: 16116198
-
alpha-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor.
J Immunol. 2005 Sep 1;175(5):3309-17
PMID: 16116223
-
Glycolipid antigen induces long-term natural killer T cell anergy in mice.
J Clin Invest. 2005 Sep;115(9):2572-83
PMID: 16138194
-
Control of B-cell responses by Toll-like receptors.
Nature. 2005 Nov 17;438(7066):364-8
PMID: 16292312
-
Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d.
Proc Natl Acad Sci U S A. 2006 Mar 14;103(11):3972-7
PMID: 16537470
-
Toll-like receptor stimulation as a third signal required for activation of human naive B cells.
Eur J Immunol. 2006 Apr;36(4):810-6
PMID: 16541472
-
Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria.
Nat Immunol. 2006 Sep;7(9):978-86
PMID: 16921381
-
The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner.
Immunology. 2006 Sep;119(1):116-25
PMID: 16792697
-
alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria.
Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8461-6
PMID: 10900007
-
NKT cells - conductors of tumor immunity?
Curr Opin Immunol. 2002 Apr;14(2):165-71
PMID: 11869887
-
Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines.
J Exp Med. 2002 Mar 4;195(5):617-24
PMID: 11877484
-
Maintenance of serological memory by polyclonal activation of human memory B cells.
Science. 2002 Dec 13;298(5601):2199-202
PMID: 12481138
-
Interleukin-12 and the regulation of innate resistance and adaptive immunity.
Nat Rev Immunol. 2003 Feb;3(2):133-46
PMID: 12563297
-
The regulatory role of Valpha14 NKT cells in innate and acquired immune response.
Annu Rev Immunol. 2003;21:483-513
PMID: 12543936
-
CD1d-restricted help to B cells by human invariant natural killer T lymphocytes.
J Exp Med. 2003 Apr 21;197(8):1051-7
PMID: 12695492
-
Regulation of dendritic cell function through Toll-like receptors.
Curr Mol Med. 2003 Jun;3(4):373-85
PMID: 12776992
-
Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein.
J Exp Med. 2003 Jul 21;198(2):267-79
PMID: 12874260
-
MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile.
Expert Rev Vaccines. 2003 Apr;2(2):197-203
PMID: 12899571
-
Role of CD1d-restricted NKT cells in microbial immunity.
Infect Immun. 2003 Oct;71(10):5447-55
PMID: 14500461
-
Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function.
J Exp Med. 2003 Oct 6;198(7):1069-76
PMID: 14530376
-
NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
J Immunol. 2003 Nov 15;171(10):5140-7
PMID: 14607913
-
CD1: antigen presentation and T cell function.
Annu Rev Immunol. 2004;22:817-90
PMID: 15032598
-
NKT cells: what's in a name?
Nat Rev Immunol. 2004 Mar;4(3):231-7
PMID: 15039760
-
CD1 recognition by mouse NK1+ T lymphocytes.
Science. 1995 May 12;268(5212):863-5
PMID: 7538697